Investing.com – Diversified Healthcare Trust (NASDAQ: DHC) reported a fourth-quarter loss of $0.09 per share, better than analysts’ expected loss of $0.18 per share. Revenue was $379.57 million, below the market consensus of $393.49 million, and flat compared to the same period last year.
The company’s same-store senior housing operating portfolio (SHOP) net operating income surged 27.6% year-over-year to $38.3 million, primarily driven by higher occupancy rates and increased fees. Same-store SHOP occupancy reached 82.4%, up 90 basis points from the same period last year, while the average monthly fee rate increased by 5.8%. DHC completed the transition of 116 AlerisLife managed communities to different operators this quarter and sold 37 non-core properties for approximately $250 million, with proceeds used to fully repay the zero-coupon notes due in 2026.
In after-hours trading on Monday, the company’s stock rose 2.1% following the earnings release.
President and CEO Christopher Bilotto stated, “DHC finished a strong and active 2025 and is bringing significant positive momentum into 2026. Thanks to these initiatives, DHC was the best-performing real estate investment trust in the U.S. in 2025, with a total shareholder return of 112.6%.”
For the full fiscal year 2026, DHC issued guidance expecting SHOP net operating income of $175 million to $185 million, representing a 26% to 33% increase over 2025. The company projects total net operating income of $297 million to $313 million, normalized funds from operations (FFO) of $125 million to $140 million, or $0.52 to $0.58 per share. The median normalized FFO guidance is $0.55 per share. Due to the absence of market consensus estimates, a comparison with analyst expectations is not available.
The company’s medical office and life sciences investment portfolio had a same-store occupancy rate of 94.7% at year-end. DHC reported normalized funds from operations of $21.8 million this quarter, or $0.09 per share.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
DHC Q4 performance exceeds expectations, stock price rises
Investing.com – Diversified Healthcare Trust (NASDAQ: DHC) reported a fourth-quarter loss of $0.09 per share, better than analysts’ expected loss of $0.18 per share. Revenue was $379.57 million, below the market consensus of $393.49 million, and flat compared to the same period last year.
The company’s same-store senior housing operating portfolio (SHOP) net operating income surged 27.6% year-over-year to $38.3 million, primarily driven by higher occupancy rates and increased fees. Same-store SHOP occupancy reached 82.4%, up 90 basis points from the same period last year, while the average monthly fee rate increased by 5.8%. DHC completed the transition of 116 AlerisLife managed communities to different operators this quarter and sold 37 non-core properties for approximately $250 million, with proceeds used to fully repay the zero-coupon notes due in 2026.
In after-hours trading on Monday, the company’s stock rose 2.1% following the earnings release.
President and CEO Christopher Bilotto stated, “DHC finished a strong and active 2025 and is bringing significant positive momentum into 2026. Thanks to these initiatives, DHC was the best-performing real estate investment trust in the U.S. in 2025, with a total shareholder return of 112.6%.”
For the full fiscal year 2026, DHC issued guidance expecting SHOP net operating income of $175 million to $185 million, representing a 26% to 33% increase over 2025. The company projects total net operating income of $297 million to $313 million, normalized funds from operations (FFO) of $125 million to $140 million, or $0.52 to $0.58 per share. The median normalized FFO guidance is $0.55 per share. Due to the absence of market consensus estimates, a comparison with analyst expectations is not available.
The company’s medical office and life sciences investment portfolio had a same-store occupancy rate of 94.7% at year-end. DHC reported normalized funds from operations of $21.8 million this quarter, or $0.09 per share.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.